{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:05:52Z","timestamp":1794265552693,"version":"4.9.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1A5A2031185"],"award-info":[{"award-number":["NRF-2020R1A5A2031185"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2019R1A5A2027521"],"award-info":[{"award-number":["NRF-2019R1A5A2027521"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020M3A9G3080282"],"award-info":[{"award-number":["NRF-2020M3A9G3080282"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Research Foundation of Korea (NRF) grant funded by the Korea government"},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2022-KH127978(HV22C0079)"],"award-info":[{"award-number":["RS-2022-KH127978(HV22C0079)"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-58115-8","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T19:37:06Z","timestamp":1742845026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae induces protective immune responses in a murine model"],"prefix":"10.1038","volume":"16","author":[{"given":"Tien Duc","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9350-2840","authenticated-orcid":false,"given":"Hoang Duy","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7313-7728","authenticated-orcid":false,"given":"Giang Chau","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Seok","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9687-8093","authenticated-orcid":false,"given":"Yoonjoo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koemchhoy","family":"Khim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2023-3317","authenticated-orcid":false,"given":"Shee Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4018-3203","authenticated-orcid":false,"given":"Joon Haeng","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,24]]},"reference":[{"key":"58115_CR1","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41577-021-00583-2","volume":"22","author":"EC Lavelle","year":"2022","unstructured":"Lavelle, E. C. & Ward, R. W. Mucosal vaccines - fortifying the frontiers. Nat Rev Immunol 22, 236\u2013250 (2022).","journal-title":"Nat Rev Immunol"},{"key":"58115_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.imlet.2019.10.013","volume":"217","author":"M Li","year":"2020","unstructured":"Li, M. et al. Mucosal vaccines: Strategies and challenges. Immunol Lett 217, 116\u2013125 (2020).","journal-title":"Immunol Lett"},{"key":"58115_CR3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jconrel.2022.12.022","volume":"353","author":"SA Kim","year":"2023","unstructured":"Kim, S. A. et al. Protein-based nanocages for vaccine development. J Control Release 353, 767\u2013791 (2023).","journal-title":"J Control Release"},{"key":"58115_CR4","doi-asserted-by":"crossref","unstructured":"Bhaskar, S. & Lim, S. Engineering protein nanocages as carriers for biomedical applications. Npg Asia Mater. 9, e371 (2017).","DOI":"10.1038\/am.2016.128"},{"key":"58115_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.addr.2016.03.002","volume":"106","author":"EJ Lee","year":"2016","unstructured":"Lee, E. J., Lee, N. K. & Kim, I. S. Bioengineered protein-based nanocage for drug delivery. Adv Drug Deliver Rev 106, 157\u2013171 (2016).","journal-title":"Adv Drug Deliver Rev"},{"key":"58115_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113892","volume":"176","author":"B Zhang","year":"2021","unstructured":"Zhang, B., Tang, G., He, J., Yan, X. & Fan, K. Ferritin nanocage: A promising and designable multi-module platform for constructing dynamic nanoassembly-based drug nanocarrier. Adv Drug Deliv Rev 176, 113892 (2021).","journal-title":"Adv Drug Deliv Rev"},{"key":"58115_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41591-021-01660-8","volume":"28","author":"KV Houser","year":"2022","unstructured":"Houser, K. V. et al. Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial. Nat Med 28, 383\u2013391 (2022).","journal-title":"Nat Med"},{"key":"58115_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12202","volume":"499","author":"M Kanekiyo","year":"2013","unstructured":"Kanekiyo, M. et al. Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature 499, 102\u2013106 (2013).","journal-title":"Nature"},{"key":"58115_CR9","doi-asserted-by":"crossref","unstructured":"Rodrigues, M. Q., Alves, P. M. & Roldao, A. Functionalizing Ferritin Nanoparticles for Vaccine Development. Pharmaceutics. 13, 1621 (2021).","DOI":"10.3390\/pharmaceutics13101621"},{"key":"58115_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.nano.2013.11.003","volume":"10","author":"JA Han","year":"2014","unstructured":"Han, J. A. et al. Ferritin protein cage nanoparticles as versatile antigen delivery nanoplatforms for dendritic cell (DC)-based vaccine development. Nanomed-Nanotechnol 10, 561\u2013569 (2014).","journal-title":"Nanomed-Nanotechnol"},{"key":"58115_CR11","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nm.3927","volume":"21","author":"HM Yassine","year":"2015","unstructured":"Yassine, H. M. et al. Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection. Nat Med 21, 1065\u20131070 (2015).","journal-title":"Nat Med"},{"key":"58115_CR12","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/35066504","volume":"410","author":"FA Samatey","year":"2001","unstructured":"Samatey, F. A. et al. Structure of the bacterial flagellar protofilament and implications for a switch for supercoiling. Nature 410, 331\u2013337 (2001).","journal-title":"Nature"},{"key":"58115_CR13","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1126\/science.1215584","volume":"335","author":"SI Yoon","year":"2012","unstructured":"Yoon, S. I. et al. Structural basis of TLR5-flagellin recognition and signaling. Science 335, 859\u2013864 (2012).","journal-title":"Science"},{"key":"58115_CR14","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/ni1011","volume":"4","author":"KD Smith","year":"2003","unstructured":"Smith, K. D. et al. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat Immunol 4, 1247\u20131253 (2003).","journal-title":"Nat Immunol"},{"key":"58115_CR15","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nature10510","volume":"477","author":"Y Zhao","year":"2011","unstructured":"Zhao, Y. et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477, 596\u2013600 (2011).","journal-title":"Nature"},{"key":"58115_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2023.101330","volume":"60","author":"JH Rhee","year":"2023","unstructured":"Rhee, J. H., Khim, K., Puth, S., Choi, Y. & Lee, S. E. Deimmunization of flagellin adjuvant for clinical application. Curr Opin Virol 60, 101330 (2023).","journal-title":"Curr Opin Virol"},{"key":"58115_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/204125a0","volume":"204","author":"J Lowy","year":"1964","unstructured":"Lowy, J. & McDonough, M. W. Structure of Filaments Produced by Re-Aggregation of Salmonella Flagellin. Nature 204, 125\u2013127 (1964).","journal-title":"Nature"},{"key":"58115_CR18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/14760584.2018.1457443","volume":"17","author":"BF Cui","year":"2018","unstructured":"Cui, B. F. et al. Flagellin as a vaccine adjuvant. Expert Rev Vaccines 17, 335\u2013349 (2018).","journal-title":"Expert Rev Vaccines"},{"key":"58115_CR19","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1128\/IAI.74.1.694-702.2006","volume":"74","author":"SE Lee","year":"2006","unstructured":"Lee, S. E. et al. A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity. Infect Immun 74, 694\u2013702 (2006).","journal-title":"Infect Immun"},{"key":"58115_CR20","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.vaccine.2011.10.058","volume":"30","author":"SH Hong","year":"2012","unstructured":"Hong, S. H. et al. Intranasal administration of a flagellin-adjuvanted inactivated influenza vaccine enhances mucosal immune responses to protect mice against lethal infection. Vaccine 30, 466\u2013474 (2012).","journal-title":"Vaccine"},{"key":"58115_CR21","doi-asserted-by":"publisher","first-page":"e1081328","DOI":"10.1080\/2162402X.2015.1081328","volume":"5","author":"SE Lee","year":"2016","unstructured":"Lee, S. E. et al. Flagellin is a strong vaginal adjuvant of a therapeutic vaccine for genital cancer. Oncoimmunology 5, e1081328 (2016).","journal-title":"Oncoimmunology"},{"key":"58115_CR22","doi-asserted-by":"publisher","first-page":"eaak9537","DOI":"10.1126\/scitranslmed.aak9537","volume":"9","author":"JH Zheng","year":"2017","unstructured":"Zheng, J. H. et al. Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin. Sci Transl Med 9, eaak9537 (2017).","journal-title":"Sci Transl Med"},{"key":"58115_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121542","volume":"286","author":"S Puth","year":"2022","unstructured":"Puth, S. et al. An all-in-one adjuvanted therapeutic cancer vaccine targeting dendritic cell cytosol induces long-lived tumor suppression through NLRC4 inflammasome activation. Biomaterials 286, 121542 (2022).","journal-title":"Biomaterials"},{"key":"58115_CR24","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.1016\/j.vaccine.2011.05.095","volume":"29","author":"CT Nguyen","year":"2011","unstructured":"Nguyen, C. T., Kim, S. Y., Kim, M. S., Lee, S. E. & Rhee, J. H. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice. Vaccine 29, 5731\u20135739 (2011).","journal-title":"Vaccine"},{"key":"58115_CR25","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41385-018-0104-6","volume":"12","author":"S Puth","year":"2019","unstructured":"Puth, S. et al. A built-in adjuvant-engineered mucosal vaccine against dysbiotic periodontal diseases. Mucosal Immunol 12, 565\u2013579 (2019).","journal-title":"Mucosal Immunol"},{"key":"58115_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cbpa.2015.10.002","volume":"29","author":"SC Reddington","year":"2015","unstructured":"Reddington, S. C. & Howarth, M. Secrets of a covalent interaction for biomaterials and biotechnology: SpyTag and SpyCatcher. Curr Opin Chem Biol 29, 94\u201399 (2015).","journal-title":"Curr Opin Chem Biol"},{"key":"58115_CR27","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1039\/D0SC01878C","volume":"11","author":"AH Keeble","year":"2020","unstructured":"Keeble, A. H. & Howarth, M. Power to the protein: enhancing and combining activities using the Spy toolbox. Chem Sci 11, 7281\u20137291 (2020).","journal-title":"Chem Sci"},{"key":"58115_CR28","doi-asserted-by":"publisher","first-page":"E690","DOI":"10.1073\/pnas.1115485109","volume":"109","author":"B Zakeri","year":"2012","unstructured":"Zakeri, B. et al. Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin. Proc Natl Acad Sci USA 109, E690\u2013E697 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"58115_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.nano.2018.11.009","volume":"16","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. Ferritin nanoparticle-based SpyTag\/SpyCatcher-enabled click vaccine for tumor immunotherapy. Nanomedicine 16, 69\u201378 (2019).","journal-title":"Nanomedicine"},{"key":"58115_CR30","doi-asserted-by":"publisher","first-page":"26523","DOI":"10.1073\/pnas.1909653116","volume":"116","author":"AH Keeble","year":"2019","unstructured":"Keeble, A. H. et al. Approaching infinite affinity through engineering of peptide-protein interaction. Proc Natl Acad Sci USA 116, 26523\u201326533 (2019).","journal-title":"Proc Natl Acad Sci USA"},{"key":"58115_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jmb.2013.10.021","volume":"426","author":"L Li","year":"2014","unstructured":"Li, L., Fierer, J. O., Rapoport, T. A. & Howarth, M. Structural analysis and optimization of the covalent association between SpyCatcher and a peptide Tag. J Mol Biol 426, 309\u2013317 (2014).","journal-title":"J Mol Biol"},{"key":"58115_CR32","doi-asserted-by":"publisher","first-page":"17474","DOI":"10.1021\/jacs.8b08250","volume":"140","author":"XL Wu","year":"2018","unstructured":"Wu, X. L., Liu, Y. J., Liu, D., Sun, F. & Zhang, W. B. An Intrinsically Disordered Peptide-Peptide Stapler for Highly Efficient Protein Ligation Both in Vivo and in Vitro. J Am Chem Soc 140, 17474\u201317483 (2018).","journal-title":"J Am Chem Soc"},{"key":"58115_CR33","doi-asserted-by":"publisher","first-page":"8855","DOI":"10.1021\/acsnano.8b02805","volume":"12","author":"TUJ Bruun","year":"2018","unstructured":"Bruun, T. U. J., Andersson, A. M. C., Draper, S. J. & Howarth, M. Engineering a Rugged Nanoscaffold To Enhance Plug-and-Display Vaccination. Acs Nano 12, 8855\u20138866 (2018).","journal-title":"Acs Nano"},{"key":"58115_CR34","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41565-020-0648-y","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang, W. et al. Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B. Nat Nanotechnol 15, 406\u2013416 (2020).","journal-title":"Nat Nanotechnol"},{"key":"58115_CR35","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41586-019-1250-z","volume":"570","author":"A Escolano","year":"2019","unstructured":"Escolano, A. et al. Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature 570, 468\u2013473 (2019).","journal-title":"Nature"},{"key":"58115_CR36","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(20)31550-6","volume":"396","author":"FM de Benedictis","year":"2020","unstructured":"de Benedictis, F. M. et al. Complicated pneumonia in children. Lancet 396, 786\u2013798 (2020).","journal-title":"Lancet"},{"key":"58115_CR37","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1586\/erv.11.76","volume":"10","author":"MC Nunes","year":"2011","unstructured":"Nunes, M. C. & Madhi, S. A. Review on the immunogenicity and safety of PCV-13 in infants and toddlers. Expert Rev Vaccines 10, 951\u2013980 (2011).","journal-title":"Expert Rev Vaccines"},{"key":"58115_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00715-w","volume":"8","author":"JA Duke","year":"2023","unstructured":"Duke, J. A. & Avci, F. Y. Emerging vaccine strategies against the incessant pneumococcal disease. NPJ Vaccines 8, 122 (2023).","journal-title":"NPJ Vaccines"},{"key":"58115_CR39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-immunol-030409-101159","volume":"28","author":"FY Avci","year":"2010","unstructured":"Avci, F. Y. & Kasper, D. L. How Bacterial Carbohydrates Influence the Adaptive Immune System. Annu Rev Immunol 28, 107\u2013130 (2010).","journal-title":"Annu Rev Immunol"},{"key":"58115_CR40","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/S0140-6736(09)61114-4","volume":"374","author":"T van der Poll","year":"2009","unstructured":"van der Poll, T. & Opal, S. M. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 374, 1543\u20131556 (2009).","journal-title":"Lancet"},{"key":"58115_CR41","doi-asserted-by":"publisher","first-page":"e00520-19","DOI":"10.1128\/mSphere.00520-19","volume":"4","author":"F Avci","year":"2019","unstructured":"Avci, F. et al. Glycoconjugates: What It Would Take To Master These Well-Known yet Little-Understood Immunogens for Vaccine Development. mSphere 4, e00520-19 (2019).","journal-title":"mSphere"},{"key":"58115_CR42","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1017\/S0950268812002257","volume":"141","author":"MA Elemraid","year":"2013","unstructured":"Elemraid, M. A. et al. Impact of the 7-valent pneumococcal conjugate vaccine on the incidence of childhood pneumonia. Epidemiol Infect 141, 1697\u20131704 (2013).","journal-title":"Epidemiol Infect"},{"key":"58115_CR43","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1056\/NEJMoa1401914","volume":"371","author":"A von Gottberg","year":"2014","unstructured":"von Gottberg, A. et al. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med 371, 1889\u20131899 (2014).","journal-title":"N Engl J Med"},{"key":"58115_CR44","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.3390\/vaccines9111338","volume":"9","author":"GS Oliveira","year":"2021","unstructured":"Oliveira, G. S., Oliveira, M. L. S., Miyaji, E. N. & Rodrigues, T. C. Pneumococcal Vaccines: Past Findings, Present Work, and Future Strategies. Vaccines (Basel) 9, 1338 (2021).","journal-title":"Vaccines (Basel)"},{"key":"58115_CR45","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/21645515.2015.1052198","volume":"12","author":"ME Pichichero","year":"2016","unstructured":"Pichichero, M. E., Khan, M. N. & Xu, Q. Next generation protein based Streptococcus pneumoniae vaccines. Hum Vaccin Immunother 12, 194\u2013205 (2016).","journal-title":"Hum Vaccin Immunother"},{"key":"58115_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.826264","volume":"12","author":"JR Lane","year":"2022","unstructured":"Lane, J. R., Tata, M., Briles, D. E. & Orihuela, C. J. A Jack of All Trades: The Role of Pneumococcal Surface Protein A in the Pathogenesis of Streptococcus pneumoniae. Front Cell Infect Microbiol 12, 826264 (2022).","journal-title":"Front Cell Infect Microbiol"},{"key":"58115_CR47","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/mi.2015.5","volume":"8","author":"Y Fukuyama","year":"2015","unstructured":"Fukuyama, Y. et al. Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques. Mucosal Immunol 8, 1144\u20131153 (2015).","journal-title":"Mucosal Immunol"},{"key":"58115_CR48","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.actbio.2019.03.049","volume":"90","author":"YC Kye","year":"2019","unstructured":"Kye, Y. C. et al. Intranasal immunization with pneumococcal surface protein A in the presence of nanoparticle forming polysorbitol transporter adjuvant induces protective immunity against the Streptococcus pneumoniae infection. Acta Biomater 90, 362\u2013372 (2019).","journal-title":"Acta Biomater"},{"key":"58115_CR49","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1126\/science.1234150","volume":"340","author":"J Jardine","year":"2013","unstructured":"Jardine, J. et al. Rational HIV immunogen design to target specific germline B cell receptors. Science 340, 711\u2013716 (2013).","journal-title":"Science"},{"key":"58115_CR50","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1126\/science.aat9120","volume":"363","author":"T Tokatlian","year":"2019","unstructured":"Tokatlian, T. et al. Innate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers. Science 363, 649\u2013654 (2019).","journal-title":"Science"},{"key":"58115_CR51","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1080\/21645515.2018.1472185","volume":"14","author":"HS Hwang","year":"2018","unstructured":"Hwang, H. S. et al. More robust gut immune responses induced by combining intranasal and sublingual routes for prime-boost immunization. Hum Vaccin Immunother 14, 2194\u20132202 (2018).","journal-title":"Hum Vaccin Immunother"},{"key":"58115_CR52","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1086\/515298","volume":"177","author":"M Anttila","year":"1998","unstructured":"Anttila, M., Eskola, J., Ahman, H. & Kayhty, H. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines. J Infect Dis 177, 1614\u20131621 (1998).","journal-title":"J Infect Dis"},{"key":"58115_CR53","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1128\/IAI.70.2.584-590.2002","volume":"70","author":"CL Vermont","year":"2002","unstructured":"Vermont, C. L. et al. Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine. Infect Immun 70, 584\u2013590 (2002).","journal-title":"Infect Immun"},{"key":"58115_CR54","doi-asserted-by":"crossref","unstructured":"Inoue, T. & Kurosaki, T. Memory B cells. Nat. Rev. Immunol. 24, 5\u201317 (2023).","DOI":"10.1038\/s41577-023-00897-3"},{"key":"58115_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113966","volume":"178","author":"M Zhu","year":"2021","unstructured":"Zhu, M. Immunological perspectives on spatial and temporal vaccine delivery. Adv Drug Deliv Rev 178, 113966 (2021).","journal-title":"Adv Drug Deliv Rev"},{"key":"58115_CR56","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/ni.1745","volume":"10","author":"TG Phan","year":"2009","unstructured":"Phan, T. G., Green, J. A., Gray, E. E., Xu, Y. & Cyster, J. G. Immune complex relay by subcapsular sinus macrophages and noncognate B cells drives antibody affinity maturation. Nat Immunol 10, 786\u2013793 (2009).","journal-title":"Nat Immunol"},{"key":"58115_CR57","doi-asserted-by":"crossref","unstructured":"Joyce, M. G. et al. SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity. bioRxiv. (2021).","DOI":"10.1107\/S0108767321098366"},{"key":"58115_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00487-9","volume":"7","author":"JN Rainho-Tomko","year":"2022","unstructured":"Rainho-Tomko, J. N. et al. Immunogenicity and protective efficacy of RSV G central conserved domain vaccine with a prefusion nanoparticle. NPJ Vaccines 7, 74 (2022).","journal-title":"NPJ Vaccines"},{"key":"58115_CR59","doi-asserted-by":"publisher","first-page":"e99881","DOI":"10.1371\/journal.pone.0099881","volume":"9","author":"T Zhou","year":"2014","unstructured":"Zhou, T. et al. Transplanting supersites of HIV-1 vulnerability. PLoS One 9, e99881 (2014).","journal-title":"PLoS One"},{"key":"58115_CR60","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.immuni.2020.11.015","volume":"53","author":"X Ma","year":"2020","unstructured":"Ma, X. et al. Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses. Immunity 53, 1315\u201330 e9 (2020).","journal-title":"Immunity"},{"key":"58115_CR61","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41564-018-0280-x","volume":"4","author":"K Subramanian","year":"2019","unstructured":"Subramanian, K. et al. Pneumolysin binds to the mannose receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival. Nat Microbiol 4, 62\u201370 (2019).","journal-title":"Nat Microbiol"},{"key":"58115_CR62","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41564-018-0147-1","volume":"3","author":"G Ercoli","year":"2018","unstructured":"Ercoli, G. et al. Intracellular replication of Streptococcus pneumoniae inside splenic macrophages serves as a reservoir for septicaemia. Nat Microbiol 3, 600\u2013610 (2018).","journal-title":"Nat Microbiol"},{"key":"58115_CR63","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","volume":"50","author":"MJ McGeachy","year":"2019","unstructured":"McGeachy, M. J., Cua, D. J. & Gaffen, S. L. The IL-17 Family of Cytokines in Health and Disease. Immunity 50, 892\u2013906 (2019).","journal-title":"Immunity"},{"key":"58115_CR64","doi-asserted-by":"publisher","first-page":"e1000159","DOI":"10.1371\/journal.ppat.1000159","volume":"4","author":"YJ Lu","year":"2008","unstructured":"Lu, Y. J. et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 4, e1000159 (2008).","journal-title":"PLoS Pathog"},{"key":"58115_CR65","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3389\/fimmu.2019.00358","volume":"10","author":"E Ramos-Sevillano","year":"2019","unstructured":"Ramos-Sevillano, E., Ercoli, G. & Brown, J. S. Mechanisms of Naturally Acquired Immunity to Streptococcus pneumoniae. Front Immunol 10, 358 (2019).","journal-title":"Front Immunol"},{"key":"58115_CR66","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/mi.2016.41","volume":"10","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Cross-protective mucosal immunity mediated by memory Th17 cells against Streptococcus pneumoniae lung infection. Mucosal Immunol 10, 250\u2013259 (2017).","journal-title":"Mucosal Immunol"},{"key":"58115_CR67","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.chom.2011.01.007","volume":"9","author":"KL Moffitt","year":"2011","unstructured":"Moffitt, K. L. et al. T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization. Cell Host Microbe 9, 158\u2013165 (2011).","journal-title":"Cell Host Microbe"},{"key":"58115_CR68","doi-asserted-by":"publisher","first-page":"eade4790","DOI":"10.1126\/scitranslmed.ade4790","volume":"15","author":"AT Widge","year":"2023","unstructured":"Widge, A. T. et al. An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults. Sci Transl Med 15, eade4790 (2023).","journal-title":"Sci Transl Med"},{"key":"58115_CR69","doi-asserted-by":"crossref","unstructured":"Kelly, H. G. et al. Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation. JCI Insight. 5, e136653 (2020).","DOI":"10.1172\/jci.insight.136653"},{"key":"58115_CR70","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00792-005-0484-x","volume":"10","author":"J Tatur","year":"2006","unstructured":"Tatur, J., Hagedoorn, P. L., Overeijnder, M. L. & Hagen, W. R. A highly thermostable ferritin from the hyperthermophilic archaeal anaerobe Pyrococcus furiosus. Extremophiles 10, 139\u2013148 (2006).","journal-title":"Extremophiles"},{"key":"58115_CR71","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/jps.23375","volume":"102","author":"L Hu","year":"2013","unstructured":"Hu, L. et al. Physical characterization and formulation development of a recombinant pneumolysoid protein-based pneumococcal vaccine. J Pharm Sci 102, 387\u2013400 (2013).","journal-title":"J Pharm Sci"},{"key":"58115_CR72","doi-asserted-by":"publisher","first-page":"e10863","DOI":"10.1371\/journal.pone.0010863","volume":"5","author":"ML Oliveira","year":"2010","unstructured":"Oliveira, M. L. et al. Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice. PLoS One 5, e10863 (2010).","journal-title":"PLoS One"},{"key":"58115_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00379-4","volume":"6","author":"K Khim","year":"2021","unstructured":"Khim, K. et al. Deimmunization of flagellin for repeated administration as a vaccine adjuvant. NPJ Vaccines 6, 116 (2021).","journal-title":"NPJ Vaccines"}],"updated-by":[{"DOI":"10.1038\/s41467-025-58562-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58115-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58115-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58115-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T14:34:50Z","timestamp":1743777290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58115-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,24]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58115"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58115-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,24]]},"assertion":[{"value":"4 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-025-58562-3","URL":"https:\/\/doi.org\/10.1038\/s41467-025-58562-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2871"}}